Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
1.
Indian J Cancer ; 2012 Jan-Mar; 49(1): 27-32
Article Dans Anglais | IMSEAR | ID: sea-144548

Résumé

Context: p53 tumor suppressor gene which is a frequent target for mutations in a high percentage of oral cancer is regarded as an early event in carcinogenesis. Aim: The role of p53 was assessed in potentially malignant oral disorders (PMOD) to ascertain its prognostic significance. Settings and Design: Retrospective case series analysis was carried out on 30 paraffin-embedded tissue blocks of confirmed oral leukoplakia with dysplasia. Materials and Methods: 10 cases of each of mild, moderate, and severe dysplasia were immunohistochemically analyzed for p53 expression. The intensity of staining, intracellular localization, and basal and/or suprabasal distribution were assessed. Statistics: The intensity of p53 staining and its distribution were analyzed by the Chi-square test. The intracellular localization of p53 in different grades of dysplasia was subjected to one way ANOVA. P<0.05 was considered significant. Results: 21/30 cases of epithelial dysplasia were positive for p53 immunopositivity. Intensity of p53 expression was strong in 12 cases and weak in 9 cases (P<0.05). p53 positivity was confined to basal cells in mild dysplasia, while severe dysplasia showed both basal and suprabasal staining (P<0.05). Nuclear and cytoplasmic staining between and within the groups were F=9.027 and F=6.465 respectively with high significance noted between mild dysplasia and severe dysplasia. Conclusions: Increased p53 expressivity and greater cellular localization with increase in the severity of dysplasia indicated a direct association between the degree of epithelial dysplasia and p53 accretion, which occurs as an early event in oral carcinogenesis.


Sujets)
Adulte , Femelle , Régulation de l'expression des gènes tumoraux , Humains , Immunohistochimie/méthodes , Leucoplasie buccale/métabolisme , Leucoplasie buccale/anatomopathologie , Mâle , Maladies de la bouche/métabolisme , Maladies de la bouche/anatomopathologie , Tumeurs de la bouche/métabolisme , Tumeurs de la bouche/anatomopathologie , États précancéreux/métabolisme , États précancéreux/anatomopathologie , Pronostic , Études rétrospectives , Marqueurs biologiques tumoraux/métabolisme , Protéine p53 suppresseur de tumeur/métabolisme
SÉLECTION CITATIONS
Détails de la recherche